Healthcare provider profile · identity verified

Kimberly T Eden, MD

Family Practice · FORT WORTH, TX · NPI 1568411684

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	480	141
Amlodipine Besylate	Amlodipine Besylate	353	104
Rosuvastatin Calcium	Rosuvastatin Calcium	275	95
Levothyroxine Sodium	Levothyroxine Sodium	272	82
Lisinopril	Lisinopril	262	97
Simvastatin	Simvastatin	201	53
Metformin Hcl Er	Metformin Hcl	189	57
Losartan Potassium	Losartan Potassium	184	62
Gabapentin	Gabapentin	173	60
Metoprolol Succinate	Metoprolol Succinate	173	51
Escitalopram Oxalate	Escitalopram Oxalate	159	48
Hydrochlorothiazide	Hydrochlorothiazide	159	51
Omeprazole	Omeprazole	151	44
Trazodone Hcl	Trazodone Hcl	142	43
Pantoprazole Sodium	Pantoprazole Sodium	135	48
Duloxetine Hcl	Duloxetine Hcl	123	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	120	37
Alprazolam	Alprazolam	114	44
Montelukast Sodium	Montelukast Sodium	114	42
Bupropion Xl	Bupropion Hcl	100	30
Sertraline Hcl	Sertraline Hcl	85	25
Citalopram Hbr	Citalopram Hydrobromide	79	24
Mounjaro	Tirzepatide	79	18
Fluoxetine Hcl	Fluoxetine Hcl	78	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	77	23
Clonazepam	Clonazepam	68	17
Glipizide Er	Glipizide	68	22
Ozempic	Semaglutide	65	17
Pravastatin Sodium	Pravastatin Sodium	62	19
Tamsulosin Hcl	Tamsulosin Hcl	62	20
Furosemide	Furosemide	61	22
Fluticasone Propionate	Fluticasone Propionate	58	20
Albuterol Sulfate Hfa	Albuterol Sulfate	57	29
Spironolactone	Spironolactone	57	19
Metformin Hcl	Metformin Hcl	56	22
Venlafaxine Hcl Er	Venlafaxine Hcl	56	18
Alendronate Sodium	Alendronate Sodium	55	23
Meloxicam	Meloxicam	55	21
Estradiol	Estradiol	53	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	suppressed
Propranolol Hcl Er	Propranolol Hcl	52	15
Carvedilol	Carvedilol	50	13
Lovastatin	Lovastatin	48	12
Tramadol Hcl	Tramadol Hcl	46	20
Zolpidem Tartrate	Zolpidem Tartrate	45	16
Jardiance	Empagliflozin	44	12
Paroxetine Hcl	Paroxetine Hcl	44	11
Valsartan	Valsartan	44	11
Metoprolol Tartrate	Metoprolol Tartrate	42	16
Allopurinol	Allopurinol	41	15
Celecoxib	Celecoxib	40	15
Lorazepam	Lorazepam	40	13
Synthroid	Levothyroxine Sodium	39	12
Acetaminophen-Codeine	Acetaminophen With Codeine	38	15
Buspirone Hcl	Buspirone Hcl	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	13
Ropinirole Hcl	Ropinirole Hcl	36	12
Glimepiride	Glimepiride	33	12
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	32	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Methylprednisolone	Methylprednisolone	30	27
Potassium Chloride	Potassium Chloride	30	suppressed
Atenolol	Atenolol	28	suppressed
Diazepam	Diazepam	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	23
Januvia	Sitagliptin Phosphate	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Glipizide	Glipizide	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	11
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Risperidone	Risperidone	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	18
Acyclovir	Acyclovir	20	suppressed
Famotidine	Famotidine	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Finasteride	Finasteride	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	18
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Methocarbamol	Methocarbamol	18	16
Pregabalin	Pregabalin	18	suppressed
Felodipine Er	Felodipine	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Ramipril	Ramipril	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	13	suppressed
Prednisone	Prednisone	13	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Topiramate	Topiramate	12	suppressed
Baclofen	Baclofen	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Fluconazole	Fluconazole	11	11
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error